Moderna’s MRNA shares were lower after a news report said biotechnology was delaying the start of a Phase III trial of its experimental coronavirus vaccine. Shares of the Cambridge, Massachusetts company in the latest check fell 5.4% to $ 58.25. Healthcare website Stat News said Moderna was making changes to …
Read More »
(Reuters) – Biotech company Moderna Inc could earn tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If you lose, the value of the early stage business could collapse. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which …
Read More »
Text size Joseph Prezioso / Getty Images Shares of Modern biotechnology fell 6.2% on Thursday afternoon after health news website Stat reported that the company was delaying the start of a Phase 3 trial of its experimental Covid-19 vaccine. The report, based on quotes from unidentified sources described as “investigators,” …
Read More »
(Reuters) – Biotech company Moderna Inc could earn tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If you lose, the value of the early stage business could collapse. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which …
Read More »
(Reuters) – Moderna Inc (MRNA.O) said Thursday that it was partnering with contract pharmacist Catalent Inc (CTLT.N) to prepare 100 million initial doses of its coronavirus vaccine for the United States, starting in the third quarter of this year. FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which …
Read More »